Sagard Signs $50 Million Royalty Deal for Athenex Cancer Drug | Wall Street Journal

August 06, 2020

Stay up to date

Stay connected with the Sagard network and sign up for news.

Businesses
Overview
Private Equity
Credit
Healthcare Royalties
Venture
SPAC
Real Estate
Private Wealth

About Sagard
Who We Are
Firm History
Portfolio
Responsibility
Board of Directors

People
Team
Advisors

Media
Insights
News and Events

Montreal

1172 Sherbrooke Ouest
Montréal, QC H3A 1H6
Canada
+1 (514) 286-6248

New York

280 Park Avenue, 3F West
New York, NY 10017
United States
+1 (212) 380-5605

Florida

4850 Tamiami Trail North, Suite 301

Naples, FL 34103

United States

Toronto

161 Bay Street, Suite 5000
Toronto, ON M5J 2S1
Canada
+1 (416) 607-2250

Paris

49/51, Avenue George V
75008 Paris
France
+33 (0)1 53 83 30 00